(PharmaNewsWire.Com, March 23, 2020 ) Market Overview The Global Cardiac Biomarkers market was valued at USD xx million in 2017 and is forecasted to reach USD xx million by 2025, with a CAGR of xx% during the forecast period (2019-2026).
Market Key Players The major players of global Cardiac Biomarkers market include • Siemens Healthcare • Abbott Laboratories • Beckman Coulter • Alere Inc. • Others
Market Segmentation By Cardiac Biomarker Tests • Troponin (I or T) • Creatine kinase (CK) • Myoglobin • Galectin-3 • Other Biomarker Tests
By Applications • Acute Coronary Syndrome • Congestive Heart Failure • Myocardial infarction (MI) • Angina • Other
By Testing Location • Laboratory Testing • Point of Care Testing
"The report covers factors impacting the market, Porter 5 Forces, Market Share Analysis, Price trend analysis, Product Benchmarking, and company profiles".
Geographical Analysis • North America • Europe • South America • Asia Pacific • The Middle East and Africa
About Us DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
For more information: Sai Kiran Sales Manager at Data M Intelligence Email: info@datamintelligence.com Tel: +1 877 441 4866 Website: www.datamintelligence.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: